http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-592566-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_050c474bcf901d1d559bbd7d18115935
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
filingDate 2009-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72be2838c8da9e04702ea245f51be16c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7712d3bfbd73f2764e453f07f32d000
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b42a36f135932836e30edbaafc391926
publicationDate 2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-592566-A
titleOfInvention 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
abstract 592566 Disclosed are 3-phenyl-3-methoxy-pyrrolidine derivative of Formula 1 where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are: (+)-3-(3-Chloro-2-fluorophenyl)-3-methoxypyrrolidine; (+)-3-(3-Chloro-2-fluorophenyl)-1-ethyl-3-methoxypyrrolidine 3-(3,4-Difluorophenyl)-(1-D)-3-methoxypyrrolidin Also disclosed are pharmaceutical compositions comprising compounds of formula (I) and the use of compounds of formula (I) in the manufacture of medicaments for the treatment, prevention or alleviation of a disease or a disorder or a condition of a mammal, including a human, which disease, disorder or condition is responsive to modulation of catecholamines in the cerebral cortex.
priorityDate 2008-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421642133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422145214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46196348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421642156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46219099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67402410

Total number of triples: 39.